Lifespot Health Ltd. announced that it has provided an update on the launch of its FeverTel platform. The Company announced that on 24 June 2020 it received notification from the Therapeutic Goods Administration that its FeverTel dual mode (ear & forehead) infrared thermometer is now listed as a Class II a medical device on the Australian Register of Therapeutic Goods. The first batch of devices are in stock and ready for sale. As previously announced, the Company's BodyTel(TM) platform is being extended to incorporate Bluetooth enabled thermometers to support individual, family and organisational monitoring of body temperature and manual entry of flu and virus-related symptoms. The Company believes this will help individuals better monitor their condition, will provide healthcare professionals with reliable ongoing information and provide organizations with ongoing "back-to-office" duty of care.